Guidelines for antiretroviral therapy for HIV infection. Canadian HIV Trials Network Antiretroviral Working Group.

about

Canadian consensus guidelines for the care of HIV-positive pregnant women: putting recommendations into practice.Production of resistant HIV mutants during antiretroviral therapy.Effects of political conflict-induced treatment interruptions on HIV drug resistance

P2860

Q35099547-E57CE549-EAFB-4E9E-8FCD-E1215DCD8B7F Q35165357-0E05699D-F8FB-43F4-9062-42A97871BA11 Q37175897-2FFD26B5-2695-4E01-81A2-70931DA57A9B

P2860

Guidelines for antiretroviral therapy for HIV infection. Canadian HIV Trials Network Antiretroviral Working Group.

Item

http://www.wikidata.org/entity/Q24534187

description

1998 nî lūn-bûn

@nan

1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Guidelines for antiretroviral ...... k Antiretroviral Working Group

@nl

Guidelines for antiretroviral ...... Antiretroviral Working Group.

@ast

Guidelines for antiretroviral ...... Antiretroviral Working Group.

@en

type

Item

label

Guidelines for antiretroviral ...... k Antiretroviral Working Group

@nl

Guidelines for antiretroviral ...... Antiretroviral Working Group.

@ast

Guidelines for antiretroviral ...... Antiretroviral Working Group.

@en

prefLabel

Guidelines for antiretroviral ...... k Antiretroviral Working Group

@nl

Guidelines for antiretroviral ...... Antiretroviral Working Group.

@ast

Guidelines for antiretroviral ...... Antiretroviral Working Group.

@en

P1476

Guidelines for antiretroviral ...... k Antiretroviral Working Group

@en

P2093

Rachlis AR

http://www.w3.org/2001/XMLSchema#string

Zarowny DP

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival

Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.

Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use.

Activation of virus replication after vaccination of HIV-1-infected individuals.

P304

496-505

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

158

http://www.w3.org/2001/XMLSchema#string

P577

1998-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9627563

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

1228924

http://www.w3.org/2001/XMLSchema#string

Guidelines for antiretroviral therapy for HIV infection. Canadian HIV Trials Network Antiretroviral Working Group.

about

P2860

P2860

Guidelines for antiretroviral therapy for HIV infection. Canadian HIV Trials Network Antiretroviral Working Group.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P921

P932